Is there evidence for cognitive intervention in alzheimer disease? A systematic review of efficacy, feasibility, and cost-effectiveness

Alzheimer Disease and Associated Disorders

Volumn 27, Issue 3, 2013, Pages 195-203

  Alves, Jorge ^a   Magalhães, Rosana ^a   Thomas, Roger E ^b   Gonçalves, Óscar F ^a   Petrosyan, Agavni ^a   Sampaio, Adriana ^a  

^a UNIVERSITY OF MINHO   (Portugal)

^b UNIVERSITY OF CALGARY   (Canada)

Author keywords

Alzheimer disease; cognitive intervention; cognitive rehabilitation; cognitive stimulation; cognitive training; cost effectiveness

Indexed keywords

ALZHEIMER DISEASE; COGNITIVE REHABILITATION; COGNITIVE THERAPY; COST EFFECTIVENESS ANALYSIS; HUMAN; MEMORY; MINI MENTAL STATE EXAMINATION; PATIENT COMPLIANCE; PRIORITY JOURNAL; PSYCHOEDUCATION; RELAXATION TRAINING; REVIEW; SOCIAL INTERACTION; SOCIAL SUPPORT; SYSTEMATIC REVIEW; COST BENEFIT ANALYSIS; ECONOMICS; NEUROPSYCHOLOGICAL TEST; PROCEDURES; PSYCHOLOGY; PSYCHOTHERAPY;

ALZHEIMER DISEASE; COST-BENEFIT ANALYSIS; HUMANS; NEUROPSYCHOLOGICAL TESTS; PSYCHOTHERAPY;

EID: 84883267150     PISSN: 08930341     EISSN: None     Source Type: Journal    
DOI: 10.1097/WAD.0b013e31827bda55     Document Type: Review

References (33)

1. Thies W, Bleiler L. 2011 Alzheimer's disease facts and figures. Alzheimer's Dement. 2011;7:208-244. Available at: http://www. alz.org/downloads/Facts-Figures-2011.pdf. Accessed January 30, 2012.
2. Clare L, Woods RT. Cognitive training and cognitive rehabilitation for people with early-stage Alzheimer's disease: a review. Neuropsychol Rehabil. 2004;14:385-401.
3. Backman L, Jones S, Berger AK, et al. Multiple cognitive deficits during the transition to Alzheimer's disease. J Intern Med. 2004;256:195-204.
4. Loy C, Schneider L. Galantamine for Alzheimer's disease and mild cognitive impairment. Cochrane Database Syst Rev. 2006;1:CD001747.
5. Pepeu G, Giovannini MG. Cholinesterase inhibitors and memory. Chem Biol Interact. 2010;187:403-408.
6. Olazarán J,Mun? iz R, Reisberg B, et al. Benefits of cognitivemotor intervention in MCI and mild to moderate Alzheimer Disease. Neurology. 2004;63:2348-2353.
7. Clare L, Woods RT, Moniz Cook ED, et al. Cognitive rehabilitation and cognitive training for early-stage Alzheimer's disease and vascular dementia. Cochrane Database Syst Rev. 2003;4:CD003260.
8. Sitzer DI, Twamley EW, Jeste DV. Cognitive training in Alzheimer's disease: a meta-analysis of the literature. Acta Psychiatr Scand. 2006;114:75-90.
9. Clare L, Linden DE, Woods RT, et al. Goal-oriented cognitive rehabilitation for people with early-stage Alzheimer disease: a single-blind randomized controlled trial of clinical efficacy. Am J Geriatr Psychiatry. 2010;18:928-939.
10. Cahn-Weiner DA, Malloy PF, Rebok GW, et al. Results of a randomized placebo-controlled study of memory training for mildly impaired Alzheimer's disease patients. Appl Neuropsychol. 2003;10:215-223.
11. Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6:e1000097.
12. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Association; 1994.
13. McKhann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer's disease: report of the NINCDSADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 1984;34:939-944.
14. Review Manager (RevMan) [Computer program]. Version 5.1. Copenhagen:The Nordic Cochrane Centre, The Cochrane Collaboration, 2011.
15. Bank of England: Inflation Calculator [Bank of England web site]. Available at: http://www.bankofengland.co.uk/education/Pages/inflation/ calculator/index1.aspx. Accessed March 16, 2012.
16. Davis RN, Massman PJ, Doody RS. Cognitive intervention in Alzheimer disease: a randomized placebo-controlled study. Alzheimer Dis Assoc Disord. 2001;15:1-9.
17. Heiss WD, Kessler J, Mielke R, et al. Long-term effects of phosphatidylserine, pyritinol, and cognitive training in Alzheimer's disease. A neuropsychological, EEG, and PET investigation. Dementia. 1994;5:88-98.
18. Niu YX, Tan JP, Guan JQ, et al. Cognitive stimulation therapy in the treatment of neuropsychiatric symptoms in Alzheimer's disease: a randomized controlled trial. Clin Rehabil. 2010;24: 1102-1111.
19. Higgins JP, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557-560.
20. Knapp M, Thorgrimsen L, Patel A, et al. Cognitive stimulation therapy for people with dementia: cost-effectiveness analysis. Br J Psychiatry. 2006;188:574-880.
21. Musicco M, Salamone G, Caltagirone C, et al. Neuropsychological predictors of rapidly progressing patients with Alzheimer's disease. Dement Geriatr Cogn Disord. 2010;30: 219-228.
22. Owen AM, Hampshire A, Grahn JA, et al. Putting brain training to the test. Nature. 2010;465:775-778.
23. Small BJ, Viitanen M, Backman L. Mini-Mental State Examination item scores as predictors of Alzheimer's disease: incidence data from the Kungsholmen Project, Stockholm. J Gerontol A Biol Sci Med Sci. 1997;52:299-304.
24. Slade PD, Townes BD, Rosenbaum G, et al. The serial use of child neurocognitive tests: development versus practice effects. Psychol Assess. 2008;20:361-369.
25. Campbell M, Fitzpatrick R, Haines A, et al. Framework for design and evaluation of complex interventions to improve health. BMJ. 2000;321:694-696.
26. Chambless DL, Baker MJ, Baucom DH, et al. Update on empirically validated therapies, II. Clin Psychol. 1998;51:3-16.
27. Wolstenholme J, Fenn P, Gray A, et al. Estimating the relationship between disease progression and cost of care in dementia. Br J Psychiatr. 2002;181:36-42.
28. AD2000 Collaborative Group. Long-term donepezil treatment in 565 patients with Alzheimer's disease (AD2000): randomised double-blind trial. Lancet. 2004;363:2105-2115.
29. Hsiung GY, Feldman HH. Pharmacological treatment in moderate-to-severe Alzheimer's disease. Expert Opin Pharmacother. 2008;9:2575-2582.
30. National Institute for Health and Clinical Excellence. Dementia: Supporting People With Dementia and Their Carers in Health and Social Care. CG42. London: National Institute for Health and Clinical Excellence; 2006.
31. Small GW, Rabins PV, Barry PP, et al. Diagnosis and treatment of Alzheimer disease and related disorders: consensus statement of the American Association for Geriatric Psychiatry, the Alzheimer's Association and the American Geriatric Society. JAMA. 1997;278:1363-1371.
32. Loewenstein DA, Acevedo A, Czaja SJ, et al. Cognitive rehabilitation of mildly impaired Alzheimer disease patients on cholinesterase inhibitors. Am J Geriatr Psychiatry. 2004;12: 395-402.
33. Arkin SM. Memory training in early Alzheimer's disease: an optimistic look at the field. Am J Alzheimers Dis Other Demen. 1991;6:17-25.